Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Atherosclerosis

126 та иш

Журнал · ISSN 0021-9150

  1. Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle

    Aleksandr B. Shek, Rano Alieva, R. D. Kurbanov +4

    МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20180 иқтибос
    ABI

  2. Elevated plasma Interleukin-6 levels in patients with acute myocardial infarction

    A. Nizomov

    МақолаAdipokines, Inflammation, and Metabolic DiseasesAtherosclerosis20180 иқтибос
    ABI

  3. Low glycemic diet improves lipid profile in patients with coronary heart disease

    A. L. Alyavi, Bakhromkhon Alyavi, Jamol Uzokov

    МақолаLiver Disease Diagnosis and TreatmentAtherosclerosis20180 иқтибос
    ABI

  4. The states of interleukin-10 in plasma in patients with acute coronary syndrome

    A. Nizomov, Kh.R. Gulyamova, Malika Mukhamedova

    МақолаAtherosclerosis and Cardiovascular DiseasesAtherosclerosis20180 иқтибос
    ABI

  5. Structural Changes Brachiocephalic Arteries In Patients With Chd And Hefh Taking Into Account The Level Of Pcsk9 And Genetic Polymorphism E670G Of The Pcsk9 Gene

    Р Алиева, Aleksandr B. Shek, Р. Д. Курбанов +2

    МақолаCancer, Lipids, and MetabolismAtherosclerosis20190 иқтибос
    ABI

  6. The use of data mining methods for estimating of vascular aging

    Sh F Madrakhimov, Gulnora Rozikhodjaeva, Kodirbek Makharov

    МақолаHealthcare Systems and Public HealthAtherosclerosis20200 иқтибос
    ABI

  7. Influence of combined lipid lowering therapy on lipid components and interleukins in dyslipidemic patients with coronary artery disease after PCI

    Jamol Uzokov, Bakhromkhon Alyavi, A. Abdullaev

    МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20200 иқтибос
    ABI

  8. Evaluation of the comparative effectiveness of rosuvastatin and atorvastatin in patients with heart failure

    U. K. Kamilova, Nuriddin Nuritdinov

    МақолаLipoproteins and Cardiovascular HealthAtherosclerosis20200 иқтибос
    ABI

  9. Efficacy of clopidogrel in patients with coronary artery disease after PCI considering with genetic polymorphisms

    Jamol Uzokov, B. A. Alyavi

    МақолаAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20200 иқтибос
    ABI

  10. Referenced database for experimentally supported microrna expression and atherosclerosis associations

    А. А. Зарубин, М. С. Назаренко, Anton Markov +3

    МақолаMicroRNA in disease regulationAtherosclerosis20200 иқтибос
    ABI

  11. Factors influence compliance management of patients with coronary artery disease after acute myocardial infarction

    A. Shalaeva, N. Dadabaeva, Khilola Mirakhmedova +1

    МақолаMedication Adherence and ComplianceAtherosclerosis20200 иқтибос
    ABI

  12. Dynamics of behavioral risk factors in patients with ischemic heart disease depending on food preferences of residents of Uzbekistan

    N.M. Nurillayeva, N.T. Rajabova

    МақолаDietary Effects on HealthAtherosclerosis20200 иқтибос
    ABI

  13. Assessment of indicators of neurohormones and lipid spectrum in patients chronic heart failure

    N.M. Nurillayeva, Surayyo M. Shukurdjanova, N.B. Nuritdinova

    МақолаDiabetes Management and ResearchAtherosclerosis20200 иқтибос
    ABI

  14. Study of the dynamics of intima media thickness of common carotid artery in elderly patients with ischemic heart disease and diabetes mellitus

    Gulnora Rozikhodjaeva, Z. Ikramova, F. Ikramova

    МақолаCardiovascular Health and Disease PreventionAtherosclerosis20200 иқтибос
    ABI

  15. A program for selecting the optimal diagnostic algorithm and stratification of the risk of lower limb peripheral artery disease

    Gulnora Rozikhodjaeva, G. Aytimova, O. Juraev +2

    МақолаPeripheral Artery Disease ManagementAtherosclerosis20200 иқтибос
    ABI

  16. Clinical importance of epicardial adipose tissue in patients with coronary heart disease

    N.M. Nurillayeva, R.S. Rajabova, Surayyo M. Shukurdjanova

    МақолаCardiovascular Disease and AdiposityAtherosclerosis20200 иқтибос
    ABI

  17. Influence of MMP-3 genetic polymorphism on arterial stuffness in patients with coronary heart disease

    Р Алиева, Ulugbek Nizamov, S N Akhmedova +1

    МақолаCardiovascular Health and Disease PreventionAtherosclerosis20200 иқтибос
    ABI

  18. Coronary artery calcium score as a predictor of atherosclerosis progression in type 2 diabetic patients after transfemoral amputation

    E. Shalaeva, B. Janabaev, A. Bobabekov

    МақолаCardiac Imaging and DiagnosticsAtherosclerosis20200 иқтибос
    ABI

  19. Coronary atherosclerosis and ABO blood group

    Sh. T. Muxamedova

    МақолаBlood groups and transfusionAtherosclerosis20200 иқтибос
    ABI

  20. Occurrence of risk factors in members of Uzbek family of patients with coronary heart disease

    N.M. Nurillayeva, A.B.B. Turkistani

    МақолаHealth and Well-being StudiesAtherosclerosis20200 иқтибос
    ABI

  21. Dynamics of indicators of atherogenicity in patients with ishcemic heart disease as a result of preventive intervention

    N.M. Nurillayeva, N.B. Nuritdinova

    МақолаLiver Disease Diagnosis and TreatmentAtherosclerosis20200 иқтибос
    ABI

  22. Frequency of polymorphism of gene MTHFR in patients with ischemic heart disease in Uzbek nationality

    N.M. Nurillayeva, N.T. Rajabova, Н А Хасанова +1

    МақолаMedical and Biological SciencesAtherosclerosis20200 иқтибос
    ABI

  23. Comparative evaluation of atherosclerotic lesions of coronary arteries in patients with primary and recurrent myocardial infarction

    Нурулло Изатиллаевич Насирдинов, Nelli Uzbekova, M.A. Xujamberdiev

    МақолаCardiovascular Disease and AdiposityAtherosclerosis20200 иқтибос
    ABI

  24. Predictive importance of psycho-emotional syndrome of patients with coronary heart disease in the violation of platelet hemostatic system

    N. M. Nurillaeva, Feruza Abdumalikova

    МақолаEducation and Professional DevelopmentAtherosclerosis20210 иқтибос
    ABI

  25. Patients with symptomatic coronary artery disease are at the increased risk of worsening the course of the disease after recovery from COVID-19

    A. Shalaeva, Khilola Mirakhmedova, Alisher Shadmanov

    МақолаCOVID-19 Clinical Research StudiesAtherosclerosis20210 иқтибос
    ABI